Evicel Market Report 2026

Evicel Market Overview

• The Evicel market growth in the historic period has been driven by high intraoperative bleeding risks, limitations of mechanical hemostasis • Market expansion is supported by growth in minimally invasive surgeries, rising surgical volumes • Growth Driver: Impact Of Rising Bleeding Disorders On The Growth Of The Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Evicel Market?

Evicel is a surgical fibrin sealant made from human fibrinogen and thrombin, used to stop bleeding and promote healing by forming a clot during operations. It is widely utilized in surgeries requiring precise bleeding control, such as cardiovascular, liver, and orthopedic operations. Its compatibility with the body reduces the likelihood of adverse reactions, ensuring safety for patients. The main surgery types of evicel are orthopedic surgeries, cardiac surgeries, general surgeries, liver surgeries, and gynecological surgeries. Orthopedic surgeries involve procedures to treat musculoskeletal conditions, including fractures, joint replacements, and spinal issues. These surgeries often require the use of hemostatic agents such as evicel to control bleeding, particularly in complex procedures such as hip replacements or spinal surgeries. Various distribution channels include mainly hospital pharmacies, surgical supply distributors, and outpatient surgery centers and are used in hospitals, specialty clinics, and others.

What Is The Evicel Market Growth Forecast?

The growth in the forecast period can be attributed to growth in minimally invasive surgeries, rising surgical volumes, expanding specialty clinics, innovation in surgical biomaterials, increased focus on surgical efficiency. Major trends in the forecast period include increasing use of fibrin sealants in surgery, rising demand for biocompatible hemostatic agents, growth in cardiovascular and liver surgeries, preference for human plasma derived sealants, expansion of advanced surgical procedures.

Global Evicel Market Segmentation

1) By Type of Surgery: Orthopedic Surgeries, Cardiac Surgeries, General Surgeries, Liver Surgeries, Gynecological Surgeries 2) By Distribution Channel: Hospital Pharmacies, Surgical Supply Distributors, Outpatient Surgery Centers 3) By End-User: Hospitals, Specialty Clinics, Other End-Users

What Are The Drivers Of The Evicel Market?

The rise in the prevalence of bleeding disorders is expected to propel the growth of the evicel market. Bleeding disorders are medical conditions characterized by the inability of blood to clot properly, leading to excessive bleeding or prolonged bleeding after injury or surgery. The rise in bleeding disorders can be attributed to several factors, including an increase in genetic conditions such as hemophilia, lifestyle factors such as poor nutrition and obesity, as well as the growing prevalence of chronic diseases such as liver disorders, which affect the body's ability to clot. Evicel is utilized in blood disorders as a fibrin sealant to promote hemostasis during surgical procedures. It is particularly effective in controlling bleeding in patients with coagulation challenges, including those with hemophilia or other clotting deficiencies. For instance, in May 2025, according to Pfizer Inc., a US-based biopharmaceutical corporation, in the UK, the haemophilia A and B patient population exceeded 11,800 individuals in the 2023/2024 period. Therefore, the rise in the prevalence of bleeding disorders is going to drive the growth of the evicel industry. The rise in the prevalence of chronic conditions is expected to boost the growth of evicel market. Chronic conditions are prolonged illnesses, lasting a year or more, that require continuous care or restrict daily life, such as diabetes and heart disease. Chronic conditions are on the rise due to aging populations, unhealthy habits, environmental factors, and better diagnostic capabilities, which together highlight both lifestyle and systemic influences. Evicel is commonly used as a fibrin sealant to control bleeding during surgeries, particularly in patients with chronic diseases that may impair wound healing or coagulation. Its application aids in achieving hemostasis and reducing complications associated with surgical interventions in these patients. For instance, in March 2024, according to the Office for Health Improvement & Disparities, a UK-based government department, between March 2022 and March 2023, the percentage of individuals with type 1 diabetes receiving all eight recommended care processes increased by 22%, and for type 2 diabetes, it increased by 21%, while the percentage achieving target HbA1c levels rose to 37.9%, the highest value ever. Therefore, the rise in the prevalence of chronic conditions is driving the growth of evicel industry. The rise in demand for aesthetic surgeries is expected to propel the growth of evicel market. Aesthetic surgeries refer to non-invasive or minimally invasive treatments designed to enhance physical appearance, improve skin texture, and reduce signs of aging, such as wrinkles, fine lines, and sagging skin. The increasing demand for aesthetic procedures is due to factors such as rising incomes, aging populations, social media influence, and advancements in cosmetic technology. Evicel is utilized in aesthetic surgeries to enhance wound closure and minimize post-operative complications. Its application ensures reduced scarring and improved healing, aligning with the precision demands of cosmetic procedures. For instance, in June 2024, according to the International Society of Aesthetic Plastic Surgery, a US-based professional organization dedicated to the advancement of aesthetic (cosmetic) plastic surgery, total surgical and non-surgical procedures rose by 3.4% in 2023, reaching 34.9 million. Face and head procedures saw particularly strong growth, surpassing 6.5 million cases and marking a 19.6% year-over-year increase. Therefore, the rise in demand for aesthetic surgeries is driving the growth of the evicel industry.

Key Players In The Global Evicel Market

Major companies operating in the evicel market are Johnson & Johnson (Omrix Biopharmaceuticals Ltd)

Regional Insights

North America was the largest region in the evicel market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Evicel Market?

The evicel market consists of sales of fibrin sealant kits, hemostatic applicators, wound closure aids, and spray applicators. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Evicel Market Report 2026?

The evicel market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the evicel industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.